Fibroblast Growth Factor 2 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses Fibroblast Growth Factor 2 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
D. Bradley Welling, MD, PhD (2) · NYU Langone Health (1) · SVS Institute of Dental Sciences (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Studies
Open first, then newest update. How each study uses Fibroblast Growth Factor 2 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- In-office Repair of Chronic Tympanic Membrane PerforationsActive, not recruitingPhase 1/2D. Bradley Welling, MD, PhDNCT06448039Written as Fibroblast Growth Factor 2
- Fibroblast Growth Factor Regeneration of Tympanic Membrane PerforationsCompletedPhase 2NYU Langone HealthNCT04960384Written as FGF-2
- Fibroblast Growth Factor Regeneration of Tympanic Membrane PerforationsCompletedPhase 2D. Bradley Welling, MD, PhDNCT02307916Written as FGF-2
- Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor SiteStatus unknownNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04234321Written as basic fibroblast growth factor
- Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession DefectsCompletedEarly Phase 1SVS Institute of Dental SciencesNCT04361630Written as FGF 2
Codes
What other systems call Fibroblast Growth Factor 2 · ClinicalTrials.gg INT008521
- MeSH (NLM) D016222Fibroblast Growth Factor 2One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016222 | Fibroblast Growth Factor 2 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.